2018 and Beyond: Switzerland Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025
Spending on medicines and healthcare in Switzerland witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/ expansion opportunities. Both Pharmaceutical sales and consumption are on rise and the outlook to 2025 remains robust driven by strong pharmaceutical market fundamentals.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Switzerland and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Switzerland healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Switzerland healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Switzerland pharmaceutical market insights and outlook.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Switzerland and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Switzerland healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Switzerland healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Switzerland pharmaceutical market insights and outlook.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Switzerland Pharmaceutical and Healthcare Industry Snapshot
2.2 Switzerland Pharmaceuticals Market Overview
3 SWITZERLAND PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Switzerland
3.2 Drivers and Restraints
3.2.1 Market Drivers in Switzerland Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Switzerland Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 SWITZERLAND PHARMACEUTICAL MARKET OUTLOOK
4.1 Switzerland Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Switzerland Pharmaceutical Exports, $ million, 2015- 2025
4.3 Switzerland Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Switzerland (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Switzerland (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Switzerland Prescription Drug Sales, $ Million, 2015- 2025
4.7 Switzerland Generic Drug Sales, $ Million, 2015- 2025
5 SWITZERLAND HEALTHCARE MARKET OUTLOOK
5.1 Switzerland Healthcare Expenditure Outlook, 2015- 2025
5.2 Switzerland Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Switzerland Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Switzerland Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Switzerland, 2015- 2025
6 SWITZERLAND HEALTHCARE MARKET STATISTICS
6.1 Switzerland Mortality by Disease Category, 2017
6.2 Number of Hospitals in Switzerland, 2007- 2017
6.3 Number of Hospital Beds in Switzerland, 2007- 2017
6.4 Physicians Count in Switzerland, 2007- 2017
6.5 Pharmacists Count in Switzerland, 2007- 2017
7 SWITZERLAND CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Switzerland, 2017
7.2 Ongoing Clinical Trials by Disease Category in Switzerland, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 SWITZERLAND DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Switzerland Population Forecast by Age Group, 2005- 2025
8.2 Switzerland Population Forecast by Location, 2005- 2025
8.3 Switzerland GDP Forecast, 2005- 2025
8.4 Switzerland GDP Per Capita Forecast, 2005- 2025
8.5 Switzerland Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN SWITZERLAND PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Switzerland Pharmaceutical and Healthcare Industry Snapshot
2.2 Switzerland Pharmaceuticals Market Overview
3 SWITZERLAND PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Switzerland
3.2 Drivers and Restraints
3.2.1 Market Drivers in Switzerland Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Switzerland Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 SWITZERLAND PHARMACEUTICAL MARKET OUTLOOK
4.1 Switzerland Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Switzerland Pharmaceutical Exports, $ million, 2015- 2025
4.3 Switzerland Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Switzerland (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Switzerland (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Switzerland Prescription Drug Sales, $ Million, 2015- 2025
4.7 Switzerland Generic Drug Sales, $ Million, 2015- 2025
5 SWITZERLAND HEALTHCARE MARKET OUTLOOK
5.1 Switzerland Healthcare Expenditure Outlook, 2015- 2025
5.2 Switzerland Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Switzerland Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Switzerland Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Switzerland, 2015- 2025
6 SWITZERLAND HEALTHCARE MARKET STATISTICS
6.1 Switzerland Mortality by Disease Category, 2017
6.2 Number of Hospitals in Switzerland, 2007- 2017
6.3 Number of Hospital Beds in Switzerland, 2007- 2017
6.4 Physicians Count in Switzerland, 2007- 2017
6.5 Pharmacists Count in Switzerland, 2007- 2017
7 SWITZERLAND CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Switzerland, 2017
7.2 Ongoing Clinical Trials by Disease Category in Switzerland, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 SWITZERLAND DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Switzerland Population Forecast by Age Group, 2005- 2025
8.2 Switzerland Population Forecast by Location, 2005- 2025
8.3 Switzerland GDP Forecast, 2005- 2025
8.4 Switzerland GDP Per Capita Forecast, 2005- 2025
8.5 Switzerland Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN SWITZERLAND PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
